Company Search:
Advanced Search
Sponsored Links
Qiagen N.V. Company Snapshot
Qiagen N.V. operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Qiagen N.V. with three other pharmaceutical manufacturers in Europe: Vifor Pharma AG of Switzerland (2018 sales of 1.58 billion Swiss Francs [US$1.57 billion] of which 100% was Pharmaceutical), Krka DD Novo Mesto of Slovenia (1.33 billion Euro [US$1.50 billion] ), and Recordati SpA which is based in Italy (1.35 billion Euro [US$1.53 billion] ).

Sales Analysis. Qiagen N.V. reported sales of 1.27 billion Euro (US$1.44 billion) for the year ending December of 2018. This represents an increase of 2.4% versus 2017, when the company's sales were 1.24 billion Euro. Sales at Qiagen N.V. have increased during each of the previous five years (and since 2013, sales have increased a total of 30%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Qiagen N.V.
  Stock Performance Chart for Qiagen N.V.
  Stock Data: Recent Stock Performance:
  Current Price (4/18/2019): 34.10
(Figures in Euro)
1 Week -5.1%   13 Weeks -2.1%  
4 Weeks 4.9%   52 Weeks 27.7%  
Qiagen N.V. Key Data:
  Ticker: QGEN Country: Netherlands
  Exchanges: NAS FRA Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 1,274,633,416
(Year Ending Jan 2019).
Employees: 4,688
  Currency: Euro Market Cap: 7,689,660,707
  Fiscal Yr Ends: December Shares Outstanding: 225,509,000
  Share Type: Aandeel Closely Held Shares: 6,285,360
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.